EGFLAM-AS4

Across TCGA pan-cancer cohorts, EGFLAM-AS4 RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of EGFLAM-AS4’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where EGFLAM-AS4 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types EGFLAM-AS4 is over-expressed in tumor.

KIRC, LUSC, and LUAD are the cancer types where EGFLAM-AS4 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in EGFLAM-AS4 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	All	All	+0.009	.023	3	view →
LUSC	All	II,III,IV	+0.027	.017	1	view →
LUAD	All	All	+0.017	.038	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

EGFLAM-AS4–KIRC

Open the KIRC breakdown →